CRIS Curis Inc

USD 10.87 0.00 0
Icon

Curis Inc (CRIS) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 10.87

0.00 (0.00)%

USD 0.06B

0.02M

N/A

USD 15.00 (+37.99%)

Icon

CRIS

Curis Inc (USD)
COMMON STOCK | NSD
USD 10.87
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 0.06B

USD 15.00 (+37.99%)

USD 10.87

Curis Inc (CRIS) Stock Forecast

N/A

Based on the Curis Inc stock forecast from 0 analysts, the average analyst target price for Curis Inc is not available over the next 12 months. Curis Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Curis Inc is Bearish, which is based on 1 positive signals and 6 negative signals. At the last closing, Curis Inc’s stock price was USD 10.87. Curis Inc’s stock price has changed by +0.37% over the past week, +11.26% over the past month and -2.95% over the last year.

No recent analyst target price found for Curis Inc
No recent average analyst rating found for Curis Inc

Company Overview Curis Inc

Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule IRAK4 kinase inhibitor, which is in a Phase 1/...Read More

https://www.curis.com

Building C, Lexington, MA, United States, 02421

49

December

USD

USA

Adjusted Closing Price for Curis Inc (CRIS)

Loading...

Unadjusted Closing Price for Curis Inc (CRIS)

Loading...

Share Trading Volume for Curis Inc Shares

Loading...

Compare Performance of Curis Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for CRIS

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Curis Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc +0.69 (+0.17%) USD107.38B 29.93 21.06

ETFs Containing CRIS

Symbol Name CRIS's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Curis Inc (CRIS) Stock

Stock Target Advisor's fundamental analysis for Curis Inc's stock is Bearish.

Unfortunately we do not have enough data on CRIS's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on CRIS's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on CRIS's stock to indicate if its overvalued.

The last closing price of CRIS's stock was USD 10.87.

The most recent market capitalization for CRIS is USD 0.06B.

Unfortunately we do not have enough analyst data on CRIS's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Curis Inc's stock.

As per our most recent records Curis Inc has 49 Employees.

Curis Inc's registered address is Building C, Lexington, MA, United States, 02421. You can get more information about it from Curis Inc's website at https://www.curis.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...